China Dasheng Biotechnology Company
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CDBT research report →
Companywww.chinadashengbio.com
China Dasheng Biotechnology Company, together with its subsidiaries, engages in the production, marketing, and distribution of bacteria based products used as additives for livestock feed and crop cultivation in the People's Republic of China. It provides artificial microorganisms (AM) and high-efficiency microorganism (HM) based biological bacterium blends; and biological preservatives. The company offers AM/HM bacteria based additives for crops, including Bulgaria lactobacillus, beer microzyme, and dark red spirilla used to increase the beneficial microorganism colonies in soil; inhibit the reproduction of harmful fungi and putrefactive bacteria; and to improve nutrient absorption and reduce crop and livestock diseases.
- CEO
- Gang Chen
- IPO
- 2008
- Employees
- 689
- HQ
- Lanzhou, CN
Price Chart
Valuation
- Market Cap
- $4.10M
- P/E
- -1.52
- P/S
- 0.00
- P/B
- -1.21
- EV/EBITDA
- -4.25
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 155.49%
- ROIC
- 354.68%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $-967,000 · 0.00%
- EPS
- $-0.02 · 0.00%
- Op Income
- $-657,000
- FCF YoY
- 0.00%
Performance & Tape
- 52W High
- $0.15
- 52W Low
- $0.00
- 50D MA
- $0.06
- 200D MA
- $0.06
- Beta
- 2.26
- Avg Volume
- 6.05K
Get TickerSpark's AI analysis on CDBT
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our CDBT Coverage
We haven't published any research on CDBT yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate CDBT Report →